Back to results
CompletedPhase 3

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

NCT00601523

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

248.633.01004 Boehringer Ingelheim Investigational Site

Sun City, Arizona, United States

+118 additional locations

View on ClinicalTrials.gov
Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD). — TrialFind